Edition:
India

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

12.91USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$12.91
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,708
52-wk High
$19.00
52-wk Low
$9.66

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.99 -1.028
Sep '17 0.60 -0.869
Jun '17
FY 2016 Dec '16 0.34 -0.600
Sep '16 0.00 -0.533
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 2.12 10.20 0.00 --
Quarter Ending Sep-18 5 0.77 3.45 0.00 --
Year Ending Dec-18 5 4.76 10.80 0.00 --
Year Ending Dec-19 5 4.94 21.25 0.00 --
Earnings (per share)
Quarter Ending Jun-18 5 -0.97 -0.57 -1.31 --
Quarter Ending Sep-18 5 -1.17 -0.71 -1.58 --
Year Ending Dec-18 5 -4.44 -3.12 -5.43 --
Year Ending Dec-19 5 -5.77 -3.82 -8.27 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

Performance for Spero Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- --
13 Week -- -- -- --
26 Week -- -- -- --
52 Week -- -- -- --
YTD -- -- -- --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.08%
# of Holders: 55
Total Shares Held: 7,771,047
3 Mo. Net Change: 23,532
# New Positions: 6
# Closed Positions: 0
# Increased Positions: 7
# Reduced Positions: 2
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.